When I first heard that Senator Lindsey Graham had died suddenly after a brief illness, the details were sparse. He had recently returned from international travel. He had reportedly complained of chest pain. He had deteriorated rapidly into cardiac arrest.
Several possibilities had to be considered. A heart attack was plausible. A pulmonary embolism after a long-haul flight was reasonable. A dangerous arrhythmia, severe respiratory failure or another acute cardiovascular event could not be excluded.
I deliberately waited before discussing the case. I did not want to force a medical explanation onto a situation where the essential facts were still unknown. The subsequent report that he had suffered an aortic dissection changed the clinical question completely.
I was no longer looking at a clot travelling to the lungs or a blocked coronary artery. I was looking at catastrophic rupture of the largest blood vessel in the body.
That matters, because I have been watching aortic disease for several years. Long before this case, I had become concerned that inflammatory changes associated with the COVID era could eventually influence the trajectory of aneurysms, dissections and other major vascular events.
I am not claiming that COVID infection or vaccination caused Lindsey Graham’s death. I do not have the evidence to make that conclusion. What I am saying is that his death draws attention to a disease process I already believed required much closer investigation.
Why Aortic Dissection Is So Catastrophic
The aorta carries blood directly from the left side of the heart to the rest of the body. With every heartbeat it takes a high-pressure pulse and must expand and recoil without tearing. The aortic wall is therefore not a simple tube. It contains elastic tissue, smooth muscle and several structural layers that let it withstand enormous mechanical stress over a lifetime.
In a dissection, a tear develops in the inner lining. Blood is forced into the wall itself, separating its layers and creating a false channel.
Once that begins, it can spread rapidly.
The dissection may cut off blood flow to the brain, heart, kidneys, intestines or limbs. It may rupture into the chest or abdomen. If it ruptures around the heart, blood fills the pericardial sac and stops the heart from filling. If it ruptures freely, blood loss can be overwhelming within minutes. There is no way to compress the aorta from outside the body. Survival depends on rapid recognition, immediate blood-pressure control and, in many cases, highly complex emergency surgery.
This is why someone can appear reasonably well and then deteriorate with extraordinary speed.
In Graham’s case, the reported delay in responders reaching him was therefore clinically significant. I cannot know when the dissection began, when it ruptured, or when cardiac arrest occurred. But with an aortic catastrophe, every minute matters.
The Part of the Aorta Most People Never Hear About
What interests me most is not the tear itself. It is what may have weakened the wall before the tear occurred. Large arteries such as the aorta are too thick to draw all their oxygen and nutrients from the blood flowing through the central lumen. The outer wall is supplied by a network of tiny vessels called the vasa vasorum.
I think of these as the blood vessels that feed the blood vessel.
If the vasa vasorum become inflamed, narrowed, thrombosed or otherwise damaged, the outer aortic wall receives less oxygen. Smooth-muscle cells may become dysfunctional or die. Elastic fibres may deteriorate. The wall may gradually lose its ability to tolerate pressure.
This does not mean inflammation automatically produces a dissection. Most dissections arise in people with recognised risk factors such as hypertension, age-related degeneration, inherited connective-tissue disease, bicuspid aortic valve or an existing aneurysm.
My concern is different.
I am asking whether inflammation affecting the aortic wall or its vasa vasorum could accelerate weakness in people who were already vulnerable. That would not create an entirely new disease. It could take an existing one and make it progress faster.
Why I Keep Returning to COVID
Evidence of vascular inflammation during and after COVID infection has been present since the early stages of the pandemic. PET imaging studies identified inflammatory activity in large arteries, including the aorta, particularly after severe disease.
COVID is not simply a respiratory infection. It can affect endothelial cells, coagulation, immune regulation and vascular tissue. It can trigger thrombosis, complement activation, macrophage recruitment and persistent inflammatory signalling.
I have also examined reports of myocarditis, pericarditis and aortic inflammation following vaccination. Individual case reports cannot establish population-level causation, but they can offer histological clues for patterns of inflammation.
One reported case, in a previously healthy young man, described myocarditis, pericarditis and fatal aortic dissection 16 days after mRNA vaccination. What mattered was not the timing. It was the reported inflammation involving the aortic wall and the vasa vasorum.
For me, that provides a possible pathological template. It suggests a mechanism by which an immune response to spike exposure through infection or vaccination, might affect the small vessels supplying the aorta.
A plausible mechanism is not proof and that distinction is critical.
But when a plausible mechanism exists alongside a changing population mortality pattern, I do not believe the responsible response is to dismiss the question. I believe it is to investigate it properly.
Balbona, E. J., et al. "Case of Myocarditis, Pericarditis, and Fatal Aortic Dissection following Covid-19 mRNA Vaccination." Biomed Sci Clin Res 3.3 (2024): 01-08.
The Mortality Trend Does Not Reassure Me
Recent US mortality data show that deaths involving aortic dissection declined for a period, then began rising again before the pandemic. The increase did not begin in 2020, and COVID cannot explain the entire trend.
But the pandemic years create an additional question.
COVID disproportionately affected older people and those with hypertension, diabetes, obesity and cardiovascular disease, the same broad population in which aortic-dissection risk is concentrated. A substantial number of vulnerable individuals died during the acute pandemic. Under ordinary circumstances, I might have expected this mortality displacement to flatten subsequent aortic-dissection mortality, at least temporarily.
Instead, the upward trajectory continued.
That does not prove acceleration. Changes in diagnosis, coding, survival, imaging and population structure may all contribute. But I do not think it should be waved away without deeper analysis.
My hypothesis is that repeated inflammatory vascular injury may be accelerating aortic disease in a subset of susceptible people. I do not know the size of that subset. I do not know the speed of progression. I do not know whether infection, vaccination, repeated spike exposure or other pandemic-related factors matter most.
Those uncertainties are precisely why research is required.
What I Would Want From the Autopsy
A routine statement that someone died from an aortic dissection is not enough to answer the question I am asking.
I would want the aorta examined systematically by an experienced cardiovascular pathologist, with multiple samples taken from the tear, the surrounding intact wall, the ascending aorta, the arch, the descending thoracic aorta and apparently normal regions.
I would want careful assessment of the elastic layers, smooth-muscle cells, medial degeneration, fibrosis, microhaemorrhage and the vasa vasorum.
Most importantly, I would want to know whether inflammatory cells were present in intact tissue away from the rupture. Inflammation immediately beside a catastrophic tear may simply be secondary to haemorrhage and tissue destruction. It cannot automatically be read as evidence of pre-existing inflammatory disease.
I would want immunostaining to identify macrophages, T cells, B cells, plasma cells, complement deposition and microthrombi. I would want infection excluded and tissue retained for molecular testing.
Even then, a single autopsy could not prove a pandemic-wide phenomenon. But it could identify a pattern worth comparing across a larger case series.
That is how meaningful science begins: not with certainty, but with careful observation, reproducible pathology and a question that can be tested.
What People Can Do Now
While the research continues, the established risk factors still matter. Everyone with hypertension should know their blood pressure and take responsibility for controlling it. Smoking should be stopped. Diabetes, cholesterol and established vascular disease should be managed properly.
Anyone with a family history of aneurysm or dissection should ask whether screening is appropriate. People with Marfan syndrome, bicuspid aortic valve, inherited connective-tissue disorders or a known aneurysm need structured surveillance.
Stimulant drugs that sharply raise blood pressure create an avoidable risk, particularly in someone with existing aortic disease.
The emergency warning also needs to be understood. Sudden severe chest, back or abdominal pain—particularly if it is tearing, ripping or unlike anything experienced before—requires immediate emergency assessment.
This is not a condition to watch at home.
A Signal Is Not a Conclusion
Lindsey Graham’s death is a tragedy. It should not be turned into proof of a political or medical narrative that the evidence cannot support. But neither should the chance to learn from it be discarded because the questions are uncomfortable.
I see this case as a signal, not a conclusion.
I see an established lethal disease, a rising mortality trajectory, evidence that COVID can affect large blood vessels, and a biologically plausible pathway involving inflammation of the aortic wall and the vasa vasorum.
What I do not yet see is the systematic pathological investigation required to connect those pieces responsibly. That is where the next stage of research must go: fewer assumptions, better autopsies, more detailed vascular pathology, serious comparison between pre-pandemic and post-pandemic cases.
When someone dies suddenly, I cannot change the outcome. But I can ask whether the tissue left behind holds information that might protect someone else.
That, for me, is the purpose of examining this case.
Vejon COVID-19 Review is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
